Saratoga Research & Investment Management’s AbbVie ABBV Stock Holding History

Saratoga Research & Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-4,525	Closed	-$438K	–	43
2017 Q4	$438K	Hold	4,525	–	–	0.03%	35
2017 Q3	$402K	Sell	4,525 -540	-11%	-$41.1K	0.03%	34
2017 Q2	$367K	Sell	5,065 -205	-4%	-$13.8K	0.03%	36
2017 Q1	$343K	Sell	5,270 -180	-3%	-$11.3K	0.03%	37
2016 Q4	$341K	Sell	5,450 -160	-3%	-$9.77K	0.03%	36
2016 Q3	$354K	Sell	5,610 -340	-6%	-$22K	0.03%	35
2016 Q2	$368K	Hold	5,950	–	–	0.03%	38
2016 Q1	$340K	Hold	5,950	–	–	0.03%	41
2015 Q4	$352K	Sell	5,950 -1,210	-17%	-$69.7K	0.03%	40
2015 Q3	$390K	Sell	7,160 -164,556	-96%	-$10.7M	0.04%	39
2015 Q2	$11.5M	Sell	171,716 -18,971	-10%	-$1.24M	1.1%	31
2015 Q1	$11.2M	Sell	190,687 -10,256	-5%	-$620K	1.04%	31
2014 Q4	$13.2M	Sell	200,943 -7,912	-4%	-$499K	1.22%	28
2014 Q3	$12.1M	Sell	208,855 -25,732	-11%	-$1.43M	1.19%	29
2014 Q2	$13.2M	Sell	234,587 -12,439	-5%	-$653K	1.32%	29
2014 Q1	$12.7M	Sell	247,026 -7,960	-3%	-$402K	1.29%	30
2013 Q4	$13.5M	Sell	254,986 -4,092	-2%	-$201K	1.43%	28
2013 Q3	$11.6M	Sell	259,078 -27,404	-10%	-$1.21M	1.36%	28
2013 Q2	$11.8M	Buy	+286,482	New	+$12.5M	1.39%	28

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Saratoga Research & Investment Management's ABBV Position: Q1 2018 in Review

Saratoga Research & Investment Management sold out of AbbVie (ABBV) in Q1 2018, closing a stake of 4,525 shares — an estimated $438K sold.

Saratoga Research & Investment Management first reported a position in ABBV in Q2 2013 and held it in 19 quarters. The position peaked at $13.5M in Q4 2013. 2,016 funds tracked by Wall St. Rank hold ABBV as of Q1 2018.

Saratoga Research & Investment Management reported no remaining AbbVie position as of Q1 2018 after selling out during the quarter.
Saratoga Research & Investment Management sold 4,525 AbbVie shares in Q1 2018, an estimated $438K.
Saratoga Research & Investment Management first reported a position in AbbVie in Q2 2013 and held it in 19 quarters.
Saratoga Research & Investment Management's AbbVie position peaked at $13.5M in Q4 2013.
2,016 funds tracked by Wall St. Rank held AbbVie as of Q1 2018.

Based on Saratoga Research & Investment Management's 13F filing for Q1 2018, filed 1 May 2018.